MEHLMAN CONSULTING, INC.

Lobbying for AMERICA'S HEALTH INSURANCE PLANS

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $90,000.00 income · posted Apr 17, 2025

Bills named in this filing 2

Lobbying activity 4

Health Issues

Advanced premium tax credits. Prescription drug pricing. Issues related to cybersecurity.

Medicare/Medicaid

Issues related to Medicare payments and Medicare Advantage Prescription Drug Pricing. Medicaid.

Taxation/Internal Revenue Code

Advanced premium tax credits Issues related to HSAs. H.R.247/S.46 - Health Care Affordability Act of 2025

Pharmacy

Prescription drug pricing.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.